Skip to Content
Merck
All Photos(1)

Documents

MABT341

Sigma-Aldrich

Anti-CD226/DNAM-1 Antibody, clone NewE1 (Azide Free)

clone NewE1, from mouse

Synonym(s):

CD226 antigen, DNAX accessory molecule 1, DNAM-1, CD_antigen=CD226

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

NewE1, monoclonal

species reactivity

human

technique(s)

activity assay: suitable
immunoprecipitation (IP): suitable
western blot: suitable

isotype

IgG1κ

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Gene Information

human ... CD226(10666)

General description

CD226/DNAM1 is a T cell expressed plasma membrane receptor protein that plays multiple roles in lymphocyte signaling, intercellular adhesion, lymphokine secretion and cytotoxic T-cell and NK cell mediated killing. CD226 activates natural killer (NK) cell-mediated cytotoxicity and is a key player in the immune synapse between killer T cells and targets. Also, because it recognizes CD155 and nectins CD226/DNAM1 is being examined as a potential anti-cancer agent because soluble CD226 directly inhibits tumor growth by binding CD155 expressed on tumor cells and down regulating proliferation. CD226/DNAM-1 is expressed on Th1, but not Th2 or Th0 cells, it is also expressed on NK cells, CD8+ T-cells, but not developing T cells. CD226/DNAM-1 is also expressed on monocytes and platelets.

Immunogen

Recombinant protein corresponding to human CD226/DNAM-1.

Application

Activity Assay Analysis: A representative lot detected CD226/DNAM-1 which induces platelet activation and aggregation (Sherrington, P.D., et al. (1997). J. Biol. Chem. 272:21735-21744).
Immunoprecipitation Analysis: A representative lot immunoprecipitated CD226/DNAM-1 in isolated surface proteins from Jurkat and platelets (Sherrington, P.D., et al. (1997). J. Biol. Chem. 272:21735-21744).
MABT341 works by western blotting under both non-reducing and reducing conditions.
Research Category
Cell Structure
Research Sub Category
Adhesion (CAMs)
This Anti-CD226/DNAM-1 Antibody, clone NewE1 (Azide Free) is validated for use in Western Blotting and Immunoprecipitation and Activity Assay for the detection of CD226/DNAM-1.

Quality

Evaluated by Western Blotting in CD226 Transfected CHO cell lysate.

Western Blotting Analysis: 1.0 µg/mL of this antibody detected CD226/DNAM-1 in 10 µg of CD226 Transfected CHO cell lysate.

Target description

~39 kDa observed

Physical form

Format: Purified
Protein G Purified
Purified mouse monoclonal IgG1κ in buffer containing PBS without preservatives.

Storage and Stability

Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Other Notes

Concentration: Please refer to lot specific datasheet.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hyung-Seung Jin et al.
Cancer immunology research, 8(7), 912-925 (2020-04-09)
Clinical trials are evaluating the efficacy of anti-TIGIT for use as single-agent therapy or in combination with programmed death 1 (PD-1)/programmed death-ligand 1 blockade. How and whether a TIGIT blockade will synergize with immunotherapies is not clear. Here, we show

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service